We’re excited to attend the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting, where leaders in neuropsychiatric drug development gather to discuss advances in CNS research and treatment. IMA Clinical Research brings extensive experience in CNS clinical trials across our nationwide site network, with experienced investigators, trained raters, and strong patient access supporting efficient recruitment and reliable study delivery.

IMA will be represented at the ASCP Annual Meeting by Jason M. Careri, MD, Principal Investigator; Alyssa Boschen, PA-C, MMS, CPI, Regional Site Director; and Kevin Short, Director, Business Development.

Schedule a meeting with our team to discuss upcoming CNS studies and partnership opportunities.